European Journal of Cancer
Volume 41, Issue 17 , Pages 2645-2654 , November 2005

Inflammation and prognosis in colorectal cancer

  • Kai Klintrup

      Affiliations

    • Department of Surgery, Oulu University Hospital, Oulu, Finland
    • ,
  • Johanna M. Mäkinen

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Saila Kauppila

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Päivi O. Väre

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Jukka Melkko

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Hannu Tuominen

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Karoliina Tuppurainen

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Jyrki Mäkelä

      Affiliations

    • Department of Surgery, Oulu University Hospital, Oulu, Finland
    • ,
  • Tuomo J. Karttunen

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • ,
  • Markus J. Mäkinen

      Affiliations

    • Department of Pathology, University of Oulu, P.O. Box 5000, Oulu, FIN-90014, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 8 537 5943; fax: +358 8 537 5953.

Received 11 February 2005 ,Revised 12 July 2005 ,Accepted 29 July 2005.

References 

  1. Tebbutt NC, Cattell E, Midgley R, et al. Systemic treatment of colorectal cancer. Eur J Cancer. 2002;38:1000–1015
  2. Haier J, Nasralla M, Nicolson GL. Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg. 2000;231:11–24
  3. Moertel CG, Fleming TR, Macdonald JS, et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes’ B2 colon cancer. J Clin Oncol. 1995;13:2936–2943
  4. The IMPACT Study Group. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999;17:1356–1363
  5. Nathanson SD, Schultz L, Tilley B, et al. Carcinomas of the colon and rectum. A comparison of staging classifications. Am Surg. 1986;52:428–433
  6. Hamilton SR, Vogelstein B, Kudo S, et al. Tumours of the colon and rectum. In:  Hamilton SR,  Aaltonen LA editor. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000;p. 103–143
  7. Higgins CA, Hatton WJ, McKerr G, et al. Macrophages and apoptotic cells in human colorectal tumours. Biologicals. 1996;24:329–332
  8. Hung K, Hayashi R, Lafond-Walker A, et al. The central role of CD4 (+) T cells in the antitumor immune response. J Exp Med. 1998;188:2357–2368
  9. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303–1306
  10. Graham DM, Appelman HD. Crohn’s-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990;3:332–335
  11. Boland CR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–5257
  12. Tuppurainen K, Mäkinen JM, Junttila O, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 2005 (in press), doi:10.1002/path.1850.
  13. Ropponen KM, Eskelinen MJ, Lipponen PK, et al. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182:318–324
  14. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, et al. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer. 2000;88:1544–1548
  15. Risio M, Reato G, di Celle PF, et al. Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res. 1996;56:5470–5474
  16. Kim H, Jen J, Vogelstein B, et al. Clinical and pathological haracteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994;145:148–156
  17. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect – a histopathological and immunohistochemical study. BMC Cancer. 2001;1:7
  18. Kristensen GB, Abeler VM, Risberg B, et al. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999;74:245–251
  19. Bryne M, Boysen M, Alfsen CG, et al. The invasive front of carcinomas. The most important area for tumour prognosis?. Anticancer Res. 1998;18:4757–4764
  20. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication?. Oral Dis. 1998;4:70–77
  21. Bryne M, Jenssen N, Boysen M. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch. 1995;427:277–281
  22. Cianchi F, Messerini L, Palomba A, et al. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?. Dis Colon Rectum. 1997;40:1170–1176
  23. Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med. 2000;29:291–298
  24. Ogawa M, Yu WG, Umehara K, et al. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression. Cancer Res. 1998;1(58):2426–2432
  25. Ohtani H, Naito Y, Saito K, et al. Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumor immunity?. Lab Invest. 1997;77:231–241
  26. Henry F, Bretaudeau L, Barbieux I, et al. Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. Res Immunol. 1998;149:673–679
  27. Newland RC, Chapuis PH, Pheils MT, et al. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer. 1981;47:1424–1429
  28. Knudsen JB, Nilsson T, Sprechler M, et al. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum. 1983;26:613–617
  29. Thomas GD, Dixon MF, Smeeton NC, et al. Observer variation in the histological grading of rectal carcinoma. J Clin Pathol. 1983;36:385–391
  30. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34:509–513

PII: S0959-8049(05)00729-X

doi: 10.1016/j.ejca.2005.07.017

European Journal of Cancer
Volume 41, Issue 17 , Pages 2645-2654 , November 2005

Article Tools

* Image Usage & Resolution